Results 161 to 170 of about 56,526 (222)

KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]

NPJ Precis Oncol
Uras IZ, Trkulja MV, Salama AKAA, Horvath J, Asnani K, Trenk C, Kubicek S, Bilban M, Moll HP, Casanova E.   +9 more
europepmc   +1 more source

Cancer Genes: Origins and Directions. [PDF]

Viruses
Vogt PK.
europepmc   +1 more source

Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network. [PDF]

Front Physiol
Hellyer NJ, Gransee HM, Sieck GC, Mantilla CB.   +3 more
europepmc   +1 more source

The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK. [PDF]

J Inflamm (Lond)
Bowden KA, Wright C, Clark S, Correa TF, Johnston SA, Marriott HM, Francis SE, Prince LR.   +7 more
europepmc   +1 more source

The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. [PDF]

J Neuroinflammation
Gryksa K, Sibilia M, Rothhammer V, Liston A, Zaiss DM.   +4 more
europepmc   +1 more source

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. [PDF]

Cancer Lett
Hinz TK, Le AT, Doan T, Ast A, Jaramillo S, Avila JT, Skhisov D, Haines S, Navarro AC, Patil T, Nemenoff RA, Heasley LE.   +11 more
europepmc   +1 more source

Shaping Cell Identity: Global Transcriptome and Pathway Shifts during Mouse Mammary Epithelial Cell Differentiation. [PDF]

Comput Struct Biotechnol J
Ahmad W, Panicker NG, Rizvi TA, Mustafa F.   +3 more
europepmc   +1 more source

New Treatment Strategies for Rare Genomic Alterations: <i>EGFR</i> Exon 20 Insertions and <i>HER2</i>-Deregulated Lung Cancer. [PDF]

Cancers (Basel)
Zullo L, Remon J.
europepmc   +1 more source

Resistance of Colorectal Cancer Stem Cells to Modern Therapies: A Systematic Review. [PDF]

Int J Mol Sci
Rustemov S, Kuandyk A, Bertleuova A, Abidi SH, Bulanin DS.   +4 more
europepmc   +1 more source